Identification of Prognosis-Related Oxidative Stress Model with Immunosuppression in HCC

Identification of Prognosis-Related Oxidative Stress Model with Immunosuppression in HCC

For hepatocellular carcinoma (HCC) patients, we attempted to establish a new oxidative stress (OS)-related prognostic model for predicting prognosis, exploring immune microenvironment, and predicting the immunotherapy response. Significantly differently expressed oxidative stress-related genes (DEOS...

Full description

Bibliographic Details
Main Authors:	Zhixuan Ren, Jiakang Zhang, Dayong Zheng, Yue Luo, Zhenghui Song, Fengsheng Chen, Aimin Li, Xinhui Liu
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Biomedicines
Subjects:	oxidative stress hepatocellular carcinoma prognostic model immune microenvironment immunotherapy
Online Access:	https://www.mdpi.com/2227-9059/11/3/695

Similar Items

Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma
by: Liang Sun, et al.
Published: (2023-06-01)

New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?
by: Arshi Khanam, et al.
Published: (2022-12-01)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
by: Maria Kotsari, et al.
Published: (2023-07-01)

A cuproptosis random forest cox score model-based evaluation of prognosis, mutation characterization, immune infiltration, and drug sensitivity in hepatocellular carcinoma
by: Ruiqi Liu, et al.
Published: (2023-03-01)

Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies
by: Erbao Chen, et al.
Published: (2024-04-01)

Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
by: Yuanxin Shi, et al.
Published: (2023-05-01)

A comprehensive computational analysis to explore the importance of SIGLECs in HCC biology
by: Senbang Yao, et al.
Published: (2023-02-01)

A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy
by: Xiang-Xu Wang, et al.
Published: (2022-09-01)

Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma
by: Zhuomao Mo, et al.
Published: (2021-02-01)

Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma
by: Hongfei Zhu, et al.
Published: (2022-09-01)

Comprehensive analysis of the clinical significance, immune infiltration, and biological role of MARCH ligases in HCC
by: Jun Cao, et al.
Published: (2022-10-01)

PTEN-related risk classification models for predicting prognosis and immunotherapy response of hepatocellular carcinoma
by: Lu Cao, et al.
Published: (2023-07-01)

Construction of m6A-based prognosis signature and prediction for immune and anti-angiogenic response
by: Xiang-Xu Wang, et al.
Published: (2022-10-01)

Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma
by: Jun Tang, et al.
Published: (2024-01-01)

Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
by: Xingyu Peng, et al.
Published: (2022-09-01)

A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients
by: Baohui Zhang, et al.
Published: (2020-09-01)

Tumor purity–associated genes influence hepatocellular carcinoma prognosis and tumor microenvironment
by: Yan Zhao, et al.
Published: (2023-06-01)

Characterization and clinical verification of immune-related genes in hepatocellular carcinoma to aid prognosis evaluation and immunotherapy
by: Jialin Qu, et al.
Published: (2023-06-01)

A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma
by: Zhan Yang, et al.
Published: (2022-12-01)

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
by: YunZhen Peng, et al.
Published: (2022-08-01)

Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors
by: Mengchen Liu, et al.
Published: (2024-04-01)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
by: Cong Chen, et al.
Published: (2022-06-01)

NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma
by: Yu-Mei Ning, et al.
Published: (2022-08-01)

AHSA1 Promotes Proliferation and EMT by Regulating ERK/CALD1 Axis in Hepatocellular Carcinoma
by: Jiakang Zhang, et al.
Published: (2022-09-01)

What Is the Role of Body Composition Assessment in HCC Management?
by: Pompilia Radu, et al.
Published: (2022-10-01)

Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
by: Oronzo Brunetti, et al.
Published: (2019-10-01)

A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells
by: Youpeng Wang, et al.
Published: (2022-04-01)

A stratification model of hepatocellular carcinoma based on expression profiles of cells in the tumor microenvironment
by: Chunting Zeng, et al.
Published: (2022-06-01)

Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma
by: Zhen Zhang, et al.
Published: (2022-07-01)

Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD
by: Hiroyuki Suzuki, et al.
Published: (2024-04-01)

An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma
by: Gen Li, et al.
Published: (2022-12-01)

A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma
by: Yi Luo, et al.
Published: (2022-11-01)

Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma
by: Huili Ren, et al.
Published: (2022-07-01)

Identification of hub genes within the CCL18 signaling pathway in hepatocellular carcinoma through bioinformatics analysis
by: Jinlei Mao, et al.
Published: (2024-03-01)

A Novel Scoring Model of Deubiquitination Patterns Predicts Prognosis and Immunotherapeutic Response in Hepatocellular Carcinoma
by: Jiahao Zhang, et al.
Published: (2023-12-01)

KIF5A upregulation in hepatocellular carcinoma: A novel prognostic biomarker associated with unique tumor microenvironment status
by: Qi Liu, et al.
Published: (2023-01-01)

Guanylate‐binding proteins signature predicts favorable prognosis, immune‐hot microenvironment, and immunotherapy response in hepatocellular carcinoma
by: Yumei Ning, et al.
Published: (2023-08-01)

Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1+ Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment
by: Liang Y, et al.
Published: (2024-02-01)

Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy
by: De-Zhen Guo, et al.
Published: (2023-02-01)

Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC
by: Aliya Qayyum, et al.
Published: (2019-11-01)